Whooping Cough Vaccine Waning: Loyola Experts Available to Comment
Embargo expired: 9/12/2012 5:00 PM EDT
Source Newsroom: Loyola University Health System
*** MEDIA ALERT ***
EMBARGO LIFTS TODAY AT 5 PM EST
WHOOPING COUGH VACCINE WANING:
LOYOLA EXPERTS AVAILABLE TO COMMENT ON NEW STUDY
The New England Journal of Medicine is releasing a study today concluding that protection against pertussis, better known as whooping cough, wanes during the five years after the fifth dose of the vaccine DTaP is given. The embargo lifts at 5 pm EST today.
Children in the United States who are vaccinated receive five doses of the DTaP vaccine which includes protection from diphtheria, tetanus and pertussis before age 7. The study concluded that the current vaccine’s protection wanes during the five years after the fifth dose is given. The vaccines are given during a child’s scheduled visits to their primary care physician. Recently, many states have recommended adults receive a DTaP booster for protection against the potentially deadly whooping cough bacteria.
Loyola University Health System infectious disease and primary care physicians are available to comment on the vaccine’s waning protection as well as what it means for adult and pediatric patients.